Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.

about

Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis Autoimmunity in 2016.Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.

P2860

Q33688739-BE27F251-54BA-427C-9CC4-B003BBD937F8 Q39337341-E41B47CC-5BB1-4143-ADB0-B481CEDE4464 Q47593445-97C6380E-20DF-44E9-BD4F-02843720D385

P2860

Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.

Item

http://www.wikidata.org/entity/Q38534871

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Cutaneous Manifestations in De ...... atures-a Comprehensive Review.

@en

type

Item

label

Cutaneous Manifestations in De ...... atures-a Comprehensive Review.

@en

prefLabel

Cutaneous Manifestations in De ...... atures-a Comprehensive Review.

@en

P1476

Cutaneous Manifestations in De ...... atures-a Comprehensive Review.

@en

P2093

Kazumitsu Sugiura

http://www.w3.org/2001/XMLSchema#string

Masashi Akiyama

http://www.w3.org/2001/XMLSchema#string

P2860

Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.

Polymyositis and dermatomyositis (second of two parts).

Polymyositis and dermatomyositis (first of two parts).

Autoantibodies in the diagnosis of systemic rheumatic diseases.

Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study.

Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.

Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.

Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study

Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease.

P2888

s12016-015-8496-5

P304

293-302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12016-015-8496-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yoshinao Muro

P577

2015-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1045199162

http://www.w3.org/2001/XMLSchema#string

P698

26100618

http://www.w3.org/2001/XMLSchema#string

P921

dermatomyositis

Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.

about

P2860

P2860

Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921